Head of Strategic Pricing Centre of Excellence; United Kingdom

Position: Head of Strategic Pricing Centre of Excellence (United Kingdom)
Make your mark for patients

We are looking for a Head of Strategic Pricing Centre of Excellence who is visionary, influential, and innovation-focused to join our Global HTA, Access & Pricing team, shaping pricing strategies and capabilities across UCB’s global portfolio based in Slough, UK or Brussels, Belgium. About the Role As Head of Strategic Pricing Centre of Excellence, and member of the Global Access and Pricing Strategy Team’s Leadership, you will act as UCB’s enterprise authority on pricing strategy, innovation, governance, and capability development.

You will define future-ready pricing approaches that balance patient access, value recognition, affordability, and sustainable growth across specialty care, rare diseases, advanced therapies, and precision medicine. Your influence will span the asset lifecycle, from early portfolio decisions and launch planning through in-market optimization, indication expansion, and lifecycle management.

As a senior strategic advisor, you will translate complex payer, policy, competitive, and evidence dynamics into clear strategic pricing recommendations for asset and executive leadership. You will also advance the use of analytics, artificial intelligence, and innovative reimbursement models to strengthen pricing decisions across the organization.

Who You’ll Work With You will collaborate with the Head of Global Access and Pricing Strategy and the respective Leadership Team, the HTA & Payer community, Global Asset Teams, Asset Payer Heads, regional and affiliate Market Access teams, HEOR, Medical, Commercial, Finance, Forecasting, Policy, Legal, Compliance, Business Development, and Digital and Data teams.

You will work across functions and geographies to align stakeholders around common pricing principles, incorporate local market realities into global strategies, and support consistent enterprise decision-making.

What You’ll DoDefine and continuously evolve UCB’s global pricing strategy, principles, governance, methodologies, and operating models.

Advise asset and executive leadership on critical pricing, access, launch, investment, and portfolio decisions.

Develop pricing strategies that balance patient access, value recognition, affordability, and long-term portfolio sustainability.

Shape global pricing readiness for major launches, including launch sequencing, competitive positioning, and international reference pricing risk.

Guide portfolio prioritization and investment decisions through pricing scenarios, simulations, forecasting, and revenue optimization.

Embed advanced analytics, AI-enabled insights, predictive modelling, and digital solutions into strategic pricing decisions.

Champion innovative approaches such as value-based pricing, outcomes-based agreements, indication-based pricing, subscription models, and novel reimbursement mechanisms.

Partner with global asset teams to ensure pricing recommendations are evidence-based and aligned with payer expectations.

Build world-class pricing capabilities through coaching, mentoring, talent development, and knowledge sharing.

Monitor global pricing trends, policy developments, healthcare reforms, and emerging market access models.

Represent UCB externally through industry bodies, payer forums, trade associations, and strategic partnerships.

Position UCB as a thought leader in pricing innovation and value-based healthcare.

Interested? For this role we’re looking for:

Bachelor’s or advanced degree in business, economics, health economics, life sciences, or a related discipline.

At least 15 years of experience in pharmaceutical pricing, market access, and value strategy, including significant global leadership responsibility.

Deep pricing expertise across multiple therapeutic areas, with demonstrated…